Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUANTUM: GS-0938 and Sofosbuvir in Chronic HCV
NCT01435044Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Sep 2011
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of psi-352938 in hepatitis C (HCV), sponsored by Gilead Sciences. Started Sep 2011; status: completed.
02
Drugs
psi-352938
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01435044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01435044.